HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis.

AuthorsT Saibara, S Onishi, Y Ogawa, S Yoshida, H Enzan
JournalLancet (London, England) (Lancet) Vol. 353 Issue 9166 Pg. 1802 (May 22 1999) ISSN: 0140-6736 [Print] England
PMID10348023 (Publication Type: Comment, Letter)
Chemical References
  • Antineoplastic Agents, Hormonal
  • Hypolipidemic Agents
  • Tamoxifen
  • Bezafibrate
Topics
  • Antineoplastic Agents, Hormonal (adverse effects)
  • Bezafibrate (therapeutic use)
  • Breast Neoplasms (drug therapy)
  • Chemotherapy, Adjuvant (adverse effects)
  • Fatty Liver (chemically induced, complications, prevention & control)
  • Female
  • Humans
  • Hypolipidemic Agents (therapeutic use)
  • Liver Cirrhosis (chemically induced, complications, prevention & control)
  • Tamoxifen (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: